Director
DIN: 07802596
Ankush Kapoor . is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at PHARMNXT BIOTECH LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07802596.Ankush Kapoor . has previously been associated with 1 company in roles such as Designated Partner.Ankush Kapoor . is currently involved in 3 different roles. Their most recent position is with PHARMNXT EKUSE PRIVATE LIMITED as a Director. The first company Ankush Kapoor . was appointed to as a director was PHARMNXT BIOTECH LLP. Ankush Kapoor . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ankush Kapoor . is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at PHARMNXT BIOTECH LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07802596.Ankush Kapoor . has previously been associated with 1 company in roles such as Designated Partner.Ankush Kapoor . is currently involved in 3 different roles. Their most recent position is with PHARMNXT EKUSE PRIVATE LIMITED as a Director. The first company Ankush Kapoor . was appointed to as a director was PHARMNXT BIOTECH LLP. Ankush Kapoor . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 10m 11 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| PHARMNXT EKUSE PRIVATE LIMITED | Director | 23-Nov-2021 |
| PHARMNXT EKUSE PRIVATE LIMITED | Individual Promoter | 23-Nov-2021 |